Smoking Cessation Aids Equally Effective in Those With Mental Health Conditions
By Lori Solomon HealthDay Reporter
THURSDAY, June 6, 2024 -- Popular smoking cessation aids are equally effective in those with or without a history of mental health conditions, according to a study published online June 4 in PLOS Mental Health.
Sarah E. Jackson, Ph.D., from University College London, and colleagues examined whether the real-world effectiveness of popular smoking cessation aids differs between users with and without a history of mental health conditions. The analysis included 5,593 adults (2,524 with a history of at least one mental health condition) who had smoked regularly within the past year and had attempted to quit at least once in the past year.
The researchers found that participants with a history of mental health conditions were significantly more likely to report using vaping products (38.8 versus 30.7 percent without a mental health condition), prescription nicotine replacement therapy (4.8 versus 2.7 percent), and websites (4.0 versus 2.2 percent). When adjusting for covariates and use of other cessation aids, those who used vaping products (odds ratio [OR], 1.92), varenicline (OR, 1.88), or heated tobacco products (OR, 2.33) had significantly higher odds of quitting successfully compared with those who did not report using these aids.
"In conclusion, use of vaping products, varenicline, or heated tobacco products in a quit attempt was associated with significantly greater odds of successful cessation, after adjustment for use of other cessation aids and potential confounders," the authors write. "There was no evidence to suggest the effectiveness of any popular cessation aid differed according to the user’s history of mental health conditions."
Two authors disclosed ties to Pfizer and J&J, which manufacture smoking cessation medications.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted June 2024
Read this next
Nicotine Pouch Use in Teens Linked to Lower Risk for Continued Vaping
MONDAY, May 19, 2025 -- Nicotine pouch use in adolescence is associated with a lower likelihood of continued vaping, according to a study published online May 19 in...
GLP-1 Receptor Agonists Not Linked to Increased Risk of Psychiatric Adverse Events, Depression
MONDAY, May 19, 2025 -- For patients with overweight/obesity and/or diabetes, glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is not associated with an increased...
More Research Needed to Prepare People With Mental Illness for Menopause
THURSDAY, May 15, 2025 -- Few studies examine how people living with a mental illness may be best prepared for the menopause transition, considering both menopause symptoms and...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.